Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study

Objective: To compare the outcomes of transarterial chemoembolization (TACE) combined with sorafenib versus TACE alone for treating patients with unresectable hepatocellular carcinoma (HCC). Methods: This retrospective analysis included all patients receiving either TACE plus sorafenib therapy or TA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Baosheng, Wang, Wansheng, Shen, Jian, Li, Wanci, Ni, Caifang, Zhu, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400692/
https://www.ncbi.nlm.nih.gov/pubmed/30854128
http://dx.doi.org/10.7150/jca.28994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400692/
https://www.ncbi.nlm.nih.gov/pubmed/30854128
http://dx.doi.org/10.7150/jca.28994

Ejemplares similares